Raju Mohan - Dec 20, 2023 Form 4 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role
CEO and President, Director
Signature
/s/ Christopher Krueger, as Attorney-in-Fact
Stock symbol
VTYX
Transactions as of
Dec 20, 2023
Transactions value $
-$124,660
Form type
4
Date filed
12/21/2023, 08:10 PM
Previous filing
Dec 19, 2023
Next filing
Jan 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTYX Common Stock Sale -$125K -58.9K -3.61% $2.12 1.57M Dec 20, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
F2 Represents the weighted average share price of an aggregate total of 58,860 shares sold in the price range of $2.07 to $2.155. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.